PharmaEngine (4162.TWO) Stock Price
PharmaEngine Price
Over the last 14 years PharmaEngine grew revenue by 7.8% annually, reaching 911.42 M TWD. Earnings per share have grown at 0.9% per year over the last 14 years. For PharmaEngine, the net margin of 42.5% is down versus 65.1% a few years ago. At today's price the dividend yield works out to roughly 10.81%. The payout ratio is around 219% of earnings. The dividend has grown at 30.5% per year over the past 3 years. The consensus 12-month price target for PharmaEngine is 63.24 TWD, about 13.9% above where the stock trades today. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 5% above its 52-week low.
PharmaEngine stock price
PharmaEngine business model & stock analysis
Frequently asked questions about PharmaEngine
Analysts currently set an average price target of 63.24 TWD for the PharmaEngine stock (median: 63.24 TWD), implying +13.9 % versus the latest price. The consensus is based on 8 analyst ratings.
7 analysts currently rate the PharmaEngine stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect PharmaEngine to generate revenue of 1.04 B TWD and earnings per share of 3.43 TWD.
Converted at the current exchange rate, the PharmaEngine share trades at 1.53 EUR (55.50 TWD).
No history available for PharmaEngine.
The expected revenue of PharmaEngine is 1.04 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of PharmaEngine is 486.57 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of PharmaEngine is currently 16.16. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PharmaEngine stock.
The price-to-sales ratio (P/S) of PharmaEngine is currently 7.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the PharmaEngine stock.
The Eulerpool Quality Score for PharmaEngine is 4/10.
The ISIN of PharmaEngine is TW0004162003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of PharmaEngine is 4162.TWO. The ticker symbol is used to trade PharmaEngine shares on the stock exchange.
Over the past 12 months, PharmaEngine paid a dividend of 6.00 TWD . This corresponds to a dividend yield of about 10.81 %. For the coming 12 months, PharmaEngine is expected to pay a dividend of 2.00 TWD.
The current dividend yield of PharmaEngine is 10.81 %.
PharmaEngine pays a dividend, distributed in the months of August.
PharmaEngine paid dividends every year for the past 4 years.
For the upcoming 12 months, dividends amounting to 2.00 TWD are expected. This corresponds to a dividend yield of 3.60 %.
PharmaEngine is assigned to the 'Health' sector.
In the year 2025, PharmaEngine distributed 6 TWD as dividends.
The dividends of PharmaEngine are distributed in TWD.
PharmaEngine stock
PharmaEngine Peer Group
PharmaEngine Ticker
PharmaEngine FIGI
All fundamentals and in-depth analysis of PharmaEngine
Our stock analysis for PharmaEngine stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaEngine. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.